SOURCE: Brighton Markets

February 02, 2012 09:00 ET

2012 Economic Outlook - Report Highlights Petroleo Brasileiro SA (ADR) and Amarin Corporation plc (ADR)

HONG KONG--(Marketwire - Feb 2, 2012) - Today, www.BrightonMarkets.com announced new reports highlighting Petroleo Brasileiro SA (ADR) (NYSE: PBR) and Amarin Corporation plc (ADR) (NASDAQ: AMRN). Gain market insight with full analysis and research downloads available at www.BrightonMarkets.com/index.php?coa=PBR&cob=AMRN.

Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experience in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Brighton Markets is releasing new coverage on Petroleo Brasileiro SA (ADR) for its current position within the basic materials industry. Petroleo Brasileiro SA Petrobras (Petrobras) is a Brazilian integrated oil and gas company. It operates in five segments: exploration and production; refining, commercialization and transport of oil and natural gas; petrochemicals; distribution of derivatives, electrical energy, biofuels and other renewable energy sources. The full research report on Petroleo Brasileiro SA (ADR) (NYSE: PBR) is available here: www.BrightonMarkets.com/index.php?coa=PBR.

Brighton Markets has released research on Amarin Corporation plc (ADR) for its changing role within the healthcare industry. Amarin Corporation plc (Amarin) is a clinical-stage biopharmaceutical company focused on developing improved treatments for cardiovascular disease. The Company's development programs capitalize in the field of lipid science and the therapeutic benefits of essential fatty acids in cardiovascular disease. The full research report on Amarin Corporation plc (ADR) (NASDAQ: AMRN) is available here: www.BrightonMarkets.com/index.php?cob=AMRN.

About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.

Contact Information